Summary by Futu AI
Huaying Medicine-B (2552) announced that it will hold a board of directors meeting on Thursday, August 29, 2024. The main purpose of the meeting is to consider and approve the group's interim performance report and related announcements for the six months ended June 30, 2024. In addition, the meeting will also handle other matters. The notice was issued by Dr. Chen Li, CEO and executive director, on August 19, 2024.